16^th International Conference on European Immunology May 02-03, 2022 Zurich, Switzerland

R. P. Iyer, (Kris) is the co-founder and Chief Scientific Officer of Spring Bank Pharmaceuticals. He has more than 25 years' experience in drug discovery and development in diverse fields including antivirals, inflammation, and immune-oncology

Cancer Immunology

Jerald C. Sadoff is currently the Head of Early Development of the Crucell Vaccine Institute which is the Center of Excellence for Vaccine Development for Johnson & Johnson Companies Worldwide. Dr. Sadoff has spent his entire career developing vaccines against a large number of bacterial, viral and parasitic diseases, 11 of which have been licensed for human use and several currently are in Phase IIB and Phase III clinical trials. He currently serves on several IPCAVD Scientific Advisory Boards for NIH sponsored HIV vaccine efforts and is on the NIAID AIDS Vaccine Research Working Group. Over the last 35 years, he has authored over 350 articles, book chapters, and abstracts and has 18 issued patents

Vaccine Development

Pierre A. Morgon is CEO of MRGN Advisors and Senior Advisor for Switzerland at Mérieux Equity Partners. He is Chairman of the Board of Virometix, as well as Non-Executive Director to the Boards of Theradiag, of Eurocine Vaccines, of Vaccitech and of Univercells.

Medicine, Pulmonology

Senior lecturer with 14 year’s experience of HE teaching, predominantly Immunology and Cancer Biology. Supervised PhD completions in Cancer Biology, iPSC, and meningococcal vaccines.

Oncology, Cancer Genetics, Cancer Biology, Immuno-Oncology and Pharmacognosy

Krassimir Metodiev, MD, Ph.D., DSc(Med), is Head of the Department of Preclinical and Clinical Sciences, Medical University, Varna, Bulgaria; President, IMAB; Vice-President, FESCI; Referent, UICC; and Director, ARW Bioterrorism, Scientific Affairs’ Division, NATO. His specialties are immunology and clinical microbiology. He has published 240 papers, IF 174.00, 7 books on medicine, and 2 books on poetry. He is editor in chief of the Journal of IMAB and editorial board member of IJIP, EJI, CEJM, JAA, and JISAO. He has attended 120 congresses worldwide, is a plenary speaker, and has been the chairperson of several sessions and workshops. He has been guest professor in Germany (Institute for Immunology, Munich); Austria (Danube University, Krems); Norway (The Norwegian Radium Hospital, Institute for Cancer Research, Oslo); and Israel (Hadassah-Jerusalem, Rambam-Haifa, Sheba-Tel Hashomer).

Immunology, Autoimmunity

Hikmet Jamil has received his Medical degree from Baghdad University, MSc from London University and his PhD from Manchester University. He specializes in Occupational and Environmental Medicine. He has joined Michigan State University in 2015 after he left Wayne State University as an “Emeritus Professor”. He has published 20 books and 191 fi eld research articles. He has served as an international Visiting Lecturer and is one of the Founders of International Society of Iraqi Scientists and was elected in 2002 as its President until 2015. He has received several awards from academic institutions, non-profit organizations, the WHO and Governmental agencies.

Occupational and Environmental Medicine

Anil Mishra, PhD., is Professor of Medicine and Endowed Chair, Edward G. Schlieder Educational Foundation and the Director of Tulane Eosinophilic Disorder Center at the Section of Pulmonary Diseases, Tulane School of Medicine, New Orleans, LA. Earlier, Dr. Mishra served as a faculty member at Allergy and Immunology Division, Cincinnati Children's Hospital Medical Center, Cincinnati, OH and Professor Medicine, Case Western Reserve University Medical College, Cleveland, OH before joining the Tulane University School of Medicine, New Orleans, LA

Medicine, Pulmonology

Michael Roth, Head of the Pulmonary Cell Research unit at the University Hospital Basel, Switzerland, has been investigating the pathologic causative mechanisms behind asthma and COPD for the last 30 years, with the aim of developing novel treatments for these ailments

Pulmonary Cell Research, Pneumology

Ra’ed Tayseer Suleiman, MD Consultant pulmonologist, Intensivist and sleep specialist in Amman, Jordan A solo practicing Consultant pulmonologist, intensivist and sleep specialist in Amman, Jordan since Feb, 2009. Medical Director of the Intensive Care Unit at Ibn Al Haytham Hospital, Amman, JORDAN, since January, 2010 Jordanian Thoracic Society Vice president since August, 2010

Pulmonary diseases

Luiz Werber-Bandeira is the Head of clinical and experimental immunology unit - Santa Casa da Misericórdia, Rio de Janeiro - General Hospital. He has a degree in Medicine, post-doctorate in Immuno-Genetics, and PhD in medicine-immunology-dermatology from Federal University of Rio de Janeiro-UFRJ. He is also specialized in Clinical Immunology-Allergy at the Federal University of Rio de Janeiro-UFRJ. Reorganizer of the clinical and experimental immunology unit - Santa Casa da Misericórdia, Rio de Janeiro. Reorganizer of the immunology laboratory of the clinical and experimental immunology unit - Santa Casa da Misericórdia, Rio de Janeiro. Creator, Scientific organizer and president of ImmunoRio in 97, 99, 2001 and 2004. President and scientific organizer of the extra section of clinical immunology 2006, 2007, 2008, 2010, 2015... Organizer and chair of the clinical immunology & chair of the South Fluminense-Vassouras faculty. Full professor in connected Domains-Carlos Chagas medical graduate school.

Clinical and experimental immunology

Gamil G. S. Zeedan obtained Ph.D. Virology ,Cairo University Egypt , MVSCs Virology, Cairo University. BVSCs , Cairo University . Currently 2014 up to date Assistant professor at National Research Center (NRC)- Cairo-Egypt. 2010- 2013 Assistant Professor in the Department of Microbiology and Virology at Collage of Medicine and Applied Medical sciences, Saudi Arabia. He teaching the following curriculum,Medical Microbiology and Virology, Diagnostic Microbiology ,Clinical Rotation of Microbiology and Clinical Rotation Immunology & Virology. Title of supervised projects: Development of a Therapeutic Vaccine against Hepatitis B Virus - Incidence of hepatitis A , B, C ,D and E in Saudi Arabia .The laboratory diagnosis of hepatitis B virus-Human immunodeficiency virus (HIV) infection testing technologies & strategies -Hepatitis C virus virological studies and diagnosis of liver diseases. He published many publications in reputed journals supervising postgraduate students and serving as an editorial board member of reputed journals.

Microbiology and Virology

Inderpaul Birdi is an experienced traditional and keyhole (minimally invasive) heart surgeon. He works privately at The Keyhole Heart Clinic where he carries out keyhole mitral, aortic and tricuspid valve surgery, coronary bypass surgery, TAVI, atrial fibrillation ablation and general cardiac surgery. He is also one of only a handful of surgeons in the world who can perform keyhole coronary bypass surgery, and keyhole aortic valve repair. He founded The Keyhole Heart Clinic to provide patients with information and clinical access to specialised minimally invasive cardiac therapies within the most prestigious hospitals in the UK.

Oncology, with a particular focus on Cancer Genetics, Cancer Biology, Immuno-Oncology and Pharmacognosy.

Wissam N. Raad MD, FACS, FRCS is a minimally invasive Attending Thoracic Surgeon at Mount Sinai Hospital, Mount Sinai West and Mount Sinai St. Luke’s Hospitals. He holds an academic appointment as an Assistant Professor of Thoracic Surgery at The Icahn School of Medicine at Mount Sinai. He is also a Director of Thoracic Robotic Surgery. Dr. Raad is certified by both the American Board of Surgery, and the American Board of Thoracic Surgery. He is also a Fellow of the Am

Cancer, Regeneration, Stem Cells in lung cancer

Gupta is a highly skilled cardiologist who specializes in Interventional cardiovascular and peripheral procedures. He completed his “Medicine residency” at Penn State University, “Cardiology Fellowship” at the University of South Florida and an “Interventional Cardiology” fellowship at The University of Chicago. He then went on to pursue additional training in “Vascular Medicine and Endovascular Intervention” at Albert Einstein College of Medicine in New York. In 2013, he was awarded the status of “Extraordinary Ability and Achievement” by the United States government. Dr Gupta has authored multiple abstracts, journal articles, book chapters and presented at multiple national and international meetings.

Interventional Cardiology and Endovascular surgery